J&J’s guselkumab tops #Humira in Phase III #psoriasis trial https://t.co/44eXwN3uea @BioCentury #biotech @JNJInnovation @JNJNews
J&J’s guselkumab tops #Humira in Phase III #psoriasis trial https://t.co/44eXwN3uea @BioCentury #biotech @JNJInnovation @JNJNews